25 XP   0   0   10

Genomma Lab Internacional S.A.B. de C.V
Buy, Hold or Sell?

Let's analyse Genomma Lab Internacional S.A.B. de C.V together

PenkeI guess you are interested in Genomma Lab Internacional S.A.B. de C.V. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Genomma Lab Internacional S.A.B. de C.V. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Genomma Lab Internacional S.A.B. de C.V

I send you an email if I find something interesting about Genomma Lab Internacional S.A.B. de C.V.

Quick analysis of Genomma Lab Internacional S.A.B. de C.V (30 sec.)










What can you expect buying and holding a share of Genomma Lab Internacional S.A.B. de C.V? (30 sec.)

How much money do you get?

How much money do you get?
₱0.19
When do you have the money?
1 year
How often do you get paid?
50.0%

What is your share worth?

Current worth
₱10.53
Expected worth in 1 year
₱12.48
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
₱5.18
Return On Investment
32.8%

For what price can you sell your share?

Current Price per Share
₱15.80
Expected price per share
₱12.39 - ₱16.31
How sure are you?
50%

1. Valuation of Genomma Lab Internacional S.A.B. de C.V (5 min.)




Live pricePrice per Share (EOD)

₱15.80

Intrinsic Value Per Share

₱15.40 - ₱43.97

Total Value Per Share

₱25.92 - ₱54.50

2. Growth of Genomma Lab Internacional S.A.B. de C.V (5 min.)




Is Genomma Lab Internacional S.A.B. de C.V growing?

Current yearPrevious yearGrowGrow %
How rich?$594.9m$590.2m$4.7m0.8%

How much money is Genomma Lab Internacional S.A.B. de C.V making?

Current yearPrevious yearGrowGrow %
Making money$81.4m$76.6m$4.7m5.9%
Net Profit Margin8.3%8.4%--

How much money comes from the company's main activities?

3. Financial Health of Genomma Lab Internacional S.A.B. de C.V (5 min.)




What can you expect buying and holding a share of Genomma Lab Internacional S.A.B. de C.V? (5 min.)

Welcome investor! Genomma Lab Internacional S.A.B. de C.V's management wants to use your money to grow the business. In return you get a share of Genomma Lab Internacional S.A.B. de C.V.

What can you expect buying and holding a share of Genomma Lab Internacional S.A.B. de C.V?

First you should know what it really means to hold a share of Genomma Lab Internacional S.A.B. de C.V. And how you can make/lose money.

Speculation

The Price per Share of Genomma Lab Internacional S.A.B. de C.V is ₱15.80. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Genomma Lab Internacional S.A.B. de C.V.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Genomma Lab Internacional S.A.B. de C.V, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₱10.53. Based on the TTM, the Book Value Change Per Share is ₱0.49 per quarter. Based on the YOY, the Book Value Change Per Share is ₱0.57 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₱0.81 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Genomma Lab Internacional S.A.B. de C.V.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.080.5%0.080.5%0.080.5%0.070.4%0.040.3%
Usd Book Value Change Per Share0.030.2%0.030.2%0.030.2%0.040.3%0.020.1%
Usd Dividend Per Share0.050.3%0.050.3%0.020.1%0.030.2%0.010.1%
Usd Total Gains Per Share0.080.5%0.080.5%0.060.4%0.070.5%0.030.2%
Usd Price Per Share0.99-0.99-1.26-1.03-1.22-
Price to Earnings Ratio11.71-11.71-16.48-15.59-10.90-
Price-to-Total Gains Ratio13.03-13.03-22.33-15.43-2.99-
Price to Book Ratio1.60-1.60-2.14-1.94-2.38-
Price-to-Total Gains Ratio13.03-13.03-22.33-15.43-2.99-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.92588
Number of shares1080
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.050.03
Usd Book Value Change Per Share0.030.04
Usd Total Gains Per Share0.080.07
Gains per Quarter (1080 shares)81.9377.93
Gains per Year (1080 shares)327.74311.70
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1204124318119193302
2408247646238385614
3612371974357578926
481649513024767711238
5102161816305959631550
61225742195871411561862
71429865228683313492174
81633989261495215412486
9183711132942107117342798
10204112363270119119263110

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.02.00.080.0%13.02.03.072.2%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.03.00.070.0%15.03.00.083.3%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%5.00.05.050.0%7.00.011.038.9%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.03.00.070.0%15.03.00.083.3%

Fundamentals of Genomma Lab Internacional S.A.B. de C.V

About Genomma Lab Internacional S.A.B. de C.V

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition. The company was incorporated in 1996 and is based in Mexico City, Mexico.

Fundamental data was last updated by Penke on 2024-04-22 19:15:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Genomma Lab Internacional S.A.B. de C.V.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Genomma Lab Internacional S.A.B. de C.V earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Genomma Lab Internacional S.A.B. de C.V to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 8.3% means that $0.08 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Genomma Lab Internacional S.A.B. de C.V:

  • The MRQ is 8.3%. The company is making a profit. +1
  • The TTM is 8.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ8.3%TTM8.3%0.0%
TTM8.3%YOY8.4%-0.2%
TTM8.3%5Y8.5%-0.3%
5Y8.5%10Y5.7%+2.9%
1.1.2. Return on Assets

Shows how efficient Genomma Lab Internacional S.A.B. de C.V is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Genomma Lab Internacional S.A.B. de C.V to the Drug Manufacturers - Specialty & Generic industry mean.
  • 6.4% Return on Assets means that Genomma Lab Internacional S.A.B. de C.V generated $0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Genomma Lab Internacional S.A.B. de C.V:

  • The MRQ is 6.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 6.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ6.4%TTM6.4%0.0%
TTM6.4%YOY6.1%+0.4%
TTM6.4%5Y5.9%+0.6%
5Y5.9%10Y3.6%+2.2%
1.1.3. Return on Equity

Shows how efficient Genomma Lab Internacional S.A.B. de C.V is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Genomma Lab Internacional S.A.B. de C.V to the Drug Manufacturers - Specialty & Generic industry mean.
  • 13.7% Return on Equity means Genomma Lab Internacional S.A.B. de C.V generated $0.14 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Genomma Lab Internacional S.A.B. de C.V:

  • The MRQ is 13.7%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 13.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ13.7%TTM13.7%0.0%
TTM13.7%YOY13.0%+0.7%
TTM13.7%5Y13.3%+0.4%
5Y13.3%10Y8.2%+5.1%

1.2. Operating Efficiency of Genomma Lab Internacional S.A.B. de C.V.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Genomma Lab Internacional S.A.B. de C.V is operating .

  • Measures how much profit Genomma Lab Internacional S.A.B. de C.V makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Genomma Lab Internacional S.A.B. de C.V to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 19.3% means the company generated $0.19  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Genomma Lab Internacional S.A.B. de C.V:

  • The MRQ is 19.3%. The company is operating efficient. +1
  • The TTM is 19.3%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ19.3%TTM19.3%0.0%
TTM19.3%YOY19.7%-0.5%
TTM19.3%5Y19.6%-0.3%
5Y19.6%10Y15.6%+4.0%
1.2.2. Operating Ratio

Measures how efficient Genomma Lab Internacional S.A.B. de C.V is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.20 means that the operating costs are $1.20 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Genomma Lab Internacional S.A.B. de C.V:

  • The MRQ is 1.203. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.203. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.203TTM1.2030.000
TTM1.203YOY1.189+0.014
TTM1.2035Y1.181+0.022
5Y1.18110Y1.179+0.001

1.3. Liquidity of Genomma Lab Internacional S.A.B. de C.V.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Genomma Lab Internacional S.A.B. de C.V is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.21 means the company has $1.21 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Genomma Lab Internacional S.A.B. de C.V:

  • The MRQ is 1.209. The company is just able to pay all its short-term debts.
  • The TTM is 1.209. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.209TTM1.2090.000
TTM1.209YOY1.753-0.544
TTM1.2095Y1.703-0.494
5Y1.70310Y1.973-0.270
1.3.2. Quick Ratio

Measures if Genomma Lab Internacional S.A.B. de C.V is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Genomma Lab Internacional S.A.B. de C.V to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.46 means the company can pay off $0.46 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Genomma Lab Internacional S.A.B. de C.V:

  • The MRQ is 0.456. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.456. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.456TTM0.4560.000
TTM0.456YOY0.644-0.188
TTM0.4565Y0.801-0.345
5Y0.80110Y0.978-0.177

1.4. Solvency of Genomma Lab Internacional S.A.B. de C.V.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Genomma Lab Internacional S.A.B. de C.V assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Genomma Lab Internacional S.A.B. de C.V to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.53 means that Genomma Lab Internacional S.A.B. de C.V assets are financed with 53.0% credit (debt) and the remaining percentage (100% - 53.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Genomma Lab Internacional S.A.B. de C.V:

  • The MRQ is 0.530. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.530. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.530TTM0.5300.000
TTM0.530YOY0.532-0.002
TTM0.5305Y0.560-0.030
5Y0.56010Y0.548+0.013
1.4.2. Debt to Equity Ratio

Measures if Genomma Lab Internacional S.A.B. de C.V is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Genomma Lab Internacional S.A.B. de C.V to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 112.8% means that company has $1.13 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Genomma Lab Internacional S.A.B. de C.V:

  • The MRQ is 1.128. The company is able to pay all its debts with equity. +1
  • The TTM is 1.128. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.128TTM1.1280.000
TTM1.128YOY1.139-0.011
TTM1.1285Y1.283-0.154
5Y1.28310Y1.242+0.041

2. Market Valuation of Genomma Lab Internacional S.A.B. de C.V

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Genomma Lab Internacional S.A.B. de C.V generates.

  • Above 15 is considered overpriced but always compare Genomma Lab Internacional S.A.B. de C.V to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 11.71 means the investor is paying $11.71 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Genomma Lab Internacional S.A.B. de C.V:

  • The EOD is 10.970. Based on the earnings, the company is underpriced. +1
  • The MRQ is 11.713. Based on the earnings, the company is underpriced. +1
  • The TTM is 11.713. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD10.970MRQ11.713-0.743
MRQ11.713TTM11.7130.000
TTM11.713YOY16.480-4.767
TTM11.7135Y15.593-3.880
5Y15.59310Y10.900+4.693
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Genomma Lab Internacional S.A.B. de C.V:

  • The EOD is 7.487. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.994. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 7.994. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD7.487MRQ7.994-0.507
MRQ7.994TTM7.9940.000
TTM7.994YOY17.082-9.088
TTM7.9945Y83.806-75.811
5Y83.80610Y51.399+32.406
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Genomma Lab Internacional S.A.B. de C.V is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Genomma Lab Internacional S.A.B. de C.V:

  • The EOD is 1.501. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.603. Based on the equity, the company is underpriced. +1
  • The TTM is 1.603. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.501MRQ1.603-0.102
MRQ1.603TTM1.6030.000
TTM1.603YOY2.140-0.537
TTM1.6035Y1.944-0.341
5Y1.94410Y2.385-0.441
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Genomma Lab Internacional S.A.B. de C.V compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.4880.4880%0.572-15%0.761-36%0.325+50%
Book Value Per Share--10.52610.5260%10.038+5%9.033+17%8.857+19%
Current Ratio--1.2091.2090%1.753-31%1.703-29%1.973-39%
Debt To Asset Ratio--0.5300.5300%0.5320%0.560-5%0.548-3%
Debt To Equity Ratio--1.1281.1280%1.139-1%1.283-12%1.242-9%
Dividend Per Share--0.8060.8060%0.390+107%0.470+71%0.235+243%
Eps--1.4401.4400%1.303+11%1.190+21%0.762+89%
Free Cash Flow Per Share--2.1102.1100%1.257+68%1.044+102%1.174+80%
Free Cash Flow To Equity Per Share--0.6980.6980%-0.207+130%0.477+46%0.696+0%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--43.970--------
Intrinsic Value_10Y_min--15.399--------
Intrinsic Value_1Y_max--2.274--------
Intrinsic Value_1Y_min--1.182--------
Intrinsic Value_3Y_max--8.457--------
Intrinsic Value_3Y_min--3.885--------
Intrinsic Value_5Y_max--16.600--------
Intrinsic Value_5Y_min--6.934--------
Market Cap15239258252.800-7%16271283969.92016271283969.9200%21553833912.840-25%17583876199.172-7%20593861684.906-21%
Net Profit Margin--0.0830.0830%0.084-2%0.085-3%0.057+46%
Operating Margin--0.1930.1930%0.197-2%0.196-1%0.156+24%
Operating Ratio--1.2031.2030%1.189+1%1.181+2%1.179+2%
Pb Ratio1.501-7%1.6031.6030%2.140-25%1.944-18%2.385-33%
Pe Ratio10.970-7%11.71311.7130%16.480-29%15.593-25%10.900+7%
Price Per Share15.800-7%16.87016.8700%21.480-21%17.514-4%20.814-19%
Price To Free Cash Flow Ratio7.487-7%7.9947.9940%17.082-53%83.806-90%51.399-84%
Price To Total Gains Ratio12.204-7%13.03113.0310%22.326-42%15.427-16%2.992+335%
Quick Ratio--0.4560.4560%0.644-29%0.801-43%0.978-53%
Return On Assets--0.0640.0640%0.061+6%0.059+10%0.036+77%
Return On Equity--0.1370.1370%0.130+5%0.133+3%0.082+67%
Total Gains Per Share--1.2951.2950%0.962+35%1.231+5%0.560+131%
Usd Book Value--594936500.000594936500.0000%590232443.600+1%530457056.520+12%513861102.880+16%
Usd Book Value Change Per Share--0.0290.0290%0.034-15%0.045-36%0.019+50%
Usd Book Value Per Share--0.6170.6170%0.588+5%0.529+17%0.519+19%
Usd Dividend Per Share--0.0470.0470%0.023+107%0.028+71%0.014+243%
Usd Eps--0.0840.0840%0.076+11%0.070+21%0.045+89%
Usd Free Cash Flow--119269752.000119269752.0000%73939839.200+61%60760781.240+96%67734462.520+76%
Usd Free Cash Flow Per Share--0.1240.1240%0.074+68%0.061+102%0.069+80%
Usd Free Cash Flow To Equity Per Share--0.0410.0410%-0.012+130%0.028+46%0.041+0%
Usd Market Cap893020533.614-7%953497240.637953497240.6370%1263054667.292-25%1030415145.271-7%1206800294.735-21%
Usd Price Per Share0.926-7%0.9890.9890%1.259-21%1.026-4%1.220-19%
Usd Profit--81407295.80081407295.8000%76641006.200+6%70804926.720+15%45445606.780+79%
Usd Revenue--985646843.200985646843.2000%907541657.400+9%828421496.160+19%750216655.200+31%
Usd Total Gains Per Share--0.0760.0760%0.056+35%0.072+5%0.033+131%
 EOD+4 -4MRQTTM+0 -0YOY+24 -115Y+24 -1110Y+28 -7

3.2. Fundamental Score

Let's check the fundamental score of Genomma Lab Internacional S.A.B. de C.V based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1510.970
Price to Book Ratio (EOD)Between0-11.501
Net Profit Margin (MRQ)Greater than00.083
Operating Margin (MRQ)Greater than00.193
Quick Ratio (MRQ)Greater than10.456
Current Ratio (MRQ)Greater than11.209
Debt to Asset Ratio (MRQ)Less than10.530
Debt to Equity Ratio (MRQ)Less than11.128
Return on Equity (MRQ)Greater than0.150.137
Return on Assets (MRQ)Greater than0.050.064
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Genomma Lab Internacional S.A.B. de C.V based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.843
Ma 20Greater thanMa 5015.214
Ma 50Greater thanMa 10014.463
Ma 100Greater thanMa 20014.169
OpenGreater thanClose14.780
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in MXN. All numbers in thousands.

Summary
Total Assets21,606,530
Total Liabilities11,454,030
Total Stockholder Equity10,152,500
 As reported
Total Liabilities 11,454,030
Total Stockholder Equity+ 10,152,500
Total Assets = 21,606,530

Assets

Total Assets21,606,530
Total Current Assets11,312,244
Long-term Assets10,294,286
Total Current Assets
Cash And Cash Equivalents 1,496,556
Net Receivables 4,270,528
Inventory 2,397,039
Other Current Assets 654,486
Total Current Assets  (as reported)11,312,244
Total Current Assets  (calculated)8,818,609
+/- 2,493,635
Long-term Assets
Property Plant Equipment 3,592,621
Intangible Assets 5,151,083
Other Assets 762,830
Long-term Assets  (as reported)10,294,286
Long-term Assets  (calculated)9,506,534
+/- 787,752

Liabilities & Shareholders' Equity

Total Current Liabilities9,356,443
Long-term Liabilities2,097,587
Total Stockholder Equity10,152,500
Total Current Liabilities
Short Long Term Debt 4,826,146
Accounts payable 1,790,380
Other Current Liabilities 983,242
Total Current Liabilities  (as reported)9,356,443
Total Current Liabilities  (calculated)7,599,768
+/- 1,756,675
Long-term Liabilities
Long term Debt 1,551,515
Capital Lease Obligations Min Short Term Debt63,613
Other Liabilities 507,810
Long-term Liabilities  (as reported)2,097,587
Long-term Liabilities  (calculated)2,122,938
+/- 25,351
Total Stockholder Equity
Retained Earnings 10,045,828
Total Stockholder Equity (as reported)10,152,500
Total Stockholder Equity (calculated)10,045,828
+/- 106,672
Other
Capital Stock1,912,967
Common Stock Shares Outstanding 964,510
Net Debt 4,881,105
Net Invested Capital 16,530,161
Net Tangible Assets 5,001,417
Net Working Capital 1,955,801
Property Plant and Equipment Gross 4,526,858



Balance Sheet

Currency in MXN. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
> Total Assets 
475,694
734,614
1,194,030
2,839,928
4,241,650
5,830,909
9,193,972
12,992,590
17,352,868
25,428,315
17,633,159
15,708,616
15,885,706
18,077,257
19,254,750
22,132,616
21,542,960
21,606,530
21,606,53021,542,96022,132,61619,254,75018,077,25715,885,70615,708,61617,633,15925,428,31517,352,86812,992,5909,193,9725,830,9094,241,6502,839,9281,194,030734,614475,694
   > Total Current Assets 
0
0
0
0
0
0
0
0
9,987,253
17,138,209
7,539,003
7,796,365
7,840,639
8,997,564
9,817,549
12,037,474
11,521,057
11,312,244
11,312,24411,521,05712,037,4749,817,5498,997,5647,840,6397,796,3657,539,00317,138,2099,987,25300000000
       Cash And Cash Equivalents 
81,674
44,729
61,351
1,315,132
1,078,416
1,454,437
1,538,520
884,416
1,759,018
1,164,454
1,673,835
1,846,229
1,069,535
1,391,372
899,662
2,048,785
1,220,905
1,496,556
1,496,5561,220,9052,048,785899,6621,391,3721,069,5351,846,2291,673,8351,164,4541,759,018884,4161,538,5201,454,4371,078,4161,315,13261,35144,72981,674
       Short-term Investments 
0
0
81,263
0
0
0
0
32,750
8,126
17,842
52,069
0
23,206
0
0
0
0
0
0000023,206052,06917,8428,12632,750000081,26300
       Net Receivables 
250,586
474,522
669,005
766,995
1,576,442
2,209,635
3,655,160
5,266,837
5,693,555
5,471,405
3,919,520
4,361,897
5,005,618
5,319,176
6,305,406
4,027,381
4,233,014
4,270,528
4,270,5284,233,0144,027,3816,305,4065,319,1765,005,6184,361,8973,919,5205,471,4055,693,5555,266,8373,655,1602,209,6351,576,442766,995669,005474,522250,586
       Other Current Assets 
31,411
37,620
42,807
127,394
85,404
73,308
333,885
999,261
1,084,498
8,889,496
786,734
439,403
501,275
589,984
704,638
938,913
1,005,453
654,486
654,4861,005,453938,913704,638589,984501,275439,403786,7348,889,4961,084,498999,261333,88573,30885,404127,39442,80737,62031,411
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
7,912,251
8,045,066
9,079,693
9,437,201
10,095,142
10,021,903
10,294,286
10,294,28610,021,90310,095,1429,437,2019,079,6938,045,0667,912,25100000000000
       Property Plant Equipment 
25,004
23,295
44,298
107,718
260,698
424,996
427,763
403,588
408,383
457,659
409,107
412,811
548,649
1,870,234
2,220,748
2,852,165
3,366,118
3,592,621
3,592,6213,366,1182,852,1652,220,7481,870,234548,649412,811409,107457,659408,383403,588427,763424,996260,698107,71844,29823,29525,004
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
51,950
52,367
0
0
0
00052,36751,9500000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
17,681
18,360
1,352,478
1,420,480
1,472,805
1,555,834
1,600,702
0
0
0
0001,600,7021,555,8341,472,8051,420,4801,352,47818,36017,68100000000
       Intangible Assets 
5,621
6,479
64,983
80,523
530,780
659,119
2,076,054
3,501,214
4,716,070
5,261,790
5,402,398
5,210,824
5,181,066
4,934,397
4,913,215
4,908,365
5,169,138
5,151,083
5,151,0835,169,1384,908,3654,913,2154,934,3975,181,0665,210,8245,402,3985,261,7904,716,0703,501,2142,076,054659,119530,78080,52364,9836,4795,621
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
44,185
160,554
94,340
92,075
93,515
220,885
168,900
168,900220,88593,51592,07594,340160,55444,18500000000000
> Total Liabilities 
310,768
388,542
606,590
527,789
1,190,916
1,719,266
3,621,072
5,973,766
8,517,424
14,925,208
8,384,509
8,915,718
8,837,038
10,649,437
11,280,642
12,498,429
11,470,734
11,454,030
11,454,03011,470,73412,498,42911,280,64210,649,4378,837,0388,915,7188,384,50914,925,2088,517,4245,973,7663,621,0721,719,2661,190,916527,789606,590388,542310,768
   > Total Current Liabilities 
297,848
366,518
579,183
523,024
1,029,329
1,547,746
2,185,524
2,629,900
3,154,086
7,595,888
2,496,069
5,100,403
6,305,022
4,485,318
5,678,539
6,613,971
6,571,141
9,356,443
9,356,4436,571,1416,613,9715,678,5394,485,3186,305,0225,100,4032,496,0697,595,8883,154,0862,629,9002,185,5241,547,7461,029,329523,024579,183366,518297,848
       Short-term Debt 
0
0
0
0
0
0
0
0
5,455,877
137,541
350,884
2,073,908
3,013,055
676,022
507,576
0
0
0
000507,576676,0223,013,0552,073,908350,884137,5415,455,87700000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
5,455,877
137,541
350,884
2,073,908
3,013,055
676,022
1,550,006
1,970,239
2,072,309
4,826,146
4,826,1462,072,3091,970,2391,550,006676,0223,013,0552,073,908350,884137,5415,455,87700000000
       Accounts payable 
161,090
111,028
78,859
377,298
594,360
969,099
1,262,328
1,218,663
1,644,125
1,554,690
670,116
1,033,545
1,098,471
1,774,441
1,881,177
1,644,766
1,439,640
1,790,380
1,790,3801,439,6401,644,7661,881,1771,774,4411,098,4711,033,545670,1161,554,6901,644,1251,218,6631,262,328969,099594,360377,29878,859111,028161,090
       Other Current Liabilities 
92,370
144,033
243,574
145,726
434,969
578,647
923,196
1,004,616
704,936
5,640,619
557,387
594,285
612,192
693,380
563,024
1,108,146
1,131,572
983,242
983,2421,131,5721,108,146563,024693,380612,192594,285557,3875,640,619704,9361,004,616923,196578,647434,969145,726243,574144,03392,370
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
3,815,315
2,532,016
6,164,119
5,602,103
5,884,458
4,899,593
2,097,587
2,097,5874,899,5935,884,4585,602,1036,164,1192,532,0163,815,31500000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
-5,455,877
-137,541
-350,884
-2,073,908
-3,013,055
-676,022
-442,406
57,612
56,535
63,613
63,61356,53557,612-442,406-676,022-3,013,055-2,073,908-350,884-137,541-5,455,87700000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
3,848
0
0
0
0
0
0
0000003,84800000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
9,337
11,624
2,462
44,185
0
0
0
0
0
0
00000044,1852,46211,6249,33700000000
> Total Stockholder Equity
166,593
345,607
584,580
2,311,363
3,041,781
4,084,553
5,531,006
6,963,107
8,711,274
10,292,786
8,987,895
6,580,872
6,846,767
7,427,820
7,974,108
9,634,187
10,072,226
10,152,500
10,152,50010,072,2269,634,1877,974,1087,427,8206,846,7676,580,8728,987,89510,292,7868,711,2746,963,1075,531,0064,084,5533,041,7812,311,363584,580345,607166,593
   Common Stock
266,316
266,316
211,439
274,923
265,361
1,921,660
1,921,660
1,921,660
1,914,306
1,914,306
1,914,306
1,914,306
1,914,306
1,914,306
1,912,967
1,912,967
1,912,967
1,912,967
1,912,9671,912,9671,912,9671,912,9671,914,3061,914,3061,914,3061,914,3061,914,3061,914,3061,921,6601,921,6601,921,660265,361274,923211,439266,316266,316
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000
   Capital Surplus 000000000000000000
   Treasury Stock00000-1,660,094-1,656,086-578,955-74,394-74,621-159,952-96,477-73,898-69,415-41,157000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
12,834
149,561
417,750
768,783
559,478
97,673
52,380
-51,471
-133,427
-145,369
-145,369-133,427-51,47152,38097,673559,478768,783417,750149,56112,83400000000



Balance Sheet

Currency in MXN. All numbers in thousands.




Cash Flow

Currency in MXN. All numbers in thousands.




Income Statement

Currency in MXN. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue17,074,203
Cost of Revenue-6,752,095
Gross Profit10,322,10810,322,108
 
Operating Income (+$)
Gross Profit10,322,108
Operating Expense-13,746,792
Operating Income3,327,411-3,424,684
 
Operating Expense (+$)
Research Development-
Selling General Administrative6,984,202
Selling And Marketing Expenses-
Operating Expense13,746,7926,984,202
 
Net Interest Income (+$)
Interest Income233,704
Interest Expense-773,814
Other Finance Cost-0
Net Interest Income-540,110
 
Pretax Income (+$)
Operating Income3,327,411
Net Interest Income-540,110
Other Non-Operating Income Expenses-
Income Before Tax (EBT)2,181,4193,327,411
EBIT - interestExpense = -773,814
1,453,821
2,227,635
Interest Expense773,814
Earnings Before Interest and Taxes (EBIT)-2,955,233
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax2,181,419
Tax Provision-727,598
Net Income From Continuing Ops1,453,8211,453,821
Net Income1,453,821
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-540,110
 

Technical Analysis of Genomma Lab Internacional S.A.B. de C.V
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Genomma Lab Internacional S.A.B. de C.V. The general trend of Genomma Lab Internacional S.A.B. de C.V is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Genomma Lab Internacional S.A.B. de C.V's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Genomma Lab Internacional S.A.B. de C.V.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 15.94 < 16.01 < 16.31.

The bearish price targets are: 13.90 > 12.39.

Tweet this
Genomma Lab Internacional S.A.B. de C.V Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Genomma Lab Internacional S.A.B. de C.V. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Genomma Lab Internacional S.A.B. de C.V Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Genomma Lab Internacional S.A.B. de C.V. The current macd is 0.10910566.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genomma Lab Internacional S.A.B. de C.V price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Genomma Lab Internacional S.A.B. de C.V. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Genomma Lab Internacional S.A.B. de C.V price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Genomma Lab Internacional S.A.B. de C.V Daily Moving Average Convergence/Divergence (MACD) ChartGenomma Lab Internacional S.A.B. de C.V Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Genomma Lab Internacional S.A.B. de C.V. The current adx is 23.15.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Genomma Lab Internacional S.A.B. de C.V shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Genomma Lab Internacional S.A.B. de C.V Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Genomma Lab Internacional S.A.B. de C.V. The current sar is 13.99.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Genomma Lab Internacional S.A.B. de C.V Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Genomma Lab Internacional S.A.B. de C.V. The current rsi is 58.84. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Genomma Lab Internacional S.A.B. de C.V Daily Relative Strength Index (RSI) ChartGenomma Lab Internacional S.A.B. de C.V Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Genomma Lab Internacional S.A.B. de C.V. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Genomma Lab Internacional S.A.B. de C.V price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Genomma Lab Internacional S.A.B. de C.V Daily Stochastic Oscillator ChartGenomma Lab Internacional S.A.B. de C.V Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Genomma Lab Internacional S.A.B. de C.V. The current cci is 65.48.

Genomma Lab Internacional S.A.B. de C.V Daily Commodity Channel Index (CCI) ChartGenomma Lab Internacional S.A.B. de C.V Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Genomma Lab Internacional S.A.B. de C.V. The current cmo is 22.11.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Genomma Lab Internacional S.A.B. de C.V Daily Chande Momentum Oscillator (CMO) ChartGenomma Lab Internacional S.A.B. de C.V Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Genomma Lab Internacional S.A.B. de C.V. The current willr is -18.8034188.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Genomma Lab Internacional S.A.B. de C.V Daily Williams %R ChartGenomma Lab Internacional S.A.B. de C.V Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Genomma Lab Internacional S.A.B. de C.V.

Genomma Lab Internacional S.A.B. de C.V Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Genomma Lab Internacional S.A.B. de C.V. The current atr is 0.61514964.

Genomma Lab Internacional S.A.B. de C.V Daily Average True Range (ATR) ChartGenomma Lab Internacional S.A.B. de C.V Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Genomma Lab Internacional S.A.B. de C.V. The current obv is -101,766,150.

Genomma Lab Internacional S.A.B. de C.V Daily On-Balance Volume (OBV) ChartGenomma Lab Internacional S.A.B. de C.V Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Genomma Lab Internacional S.A.B. de C.V. The current mfi is 46.95.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Genomma Lab Internacional S.A.B. de C.V Daily Money Flow Index (MFI) ChartGenomma Lab Internacional S.A.B. de C.V Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Genomma Lab Internacional S.A.B. de C.V.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Genomma Lab Internacional S.A.B. de C.V Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Genomma Lab Internacional S.A.B. de C.V based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.843
Ma 20Greater thanMa 5015.214
Ma 50Greater thanMa 10014.463
Ma 100Greater thanMa 20014.169
OpenGreater thanClose14.780
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Genomma Lab Internacional S.A.B. de C.V with someone you think should read this too:
  • Are you bullish or bearish on Genomma Lab Internacional S.A.B. de C.V? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Genomma Lab Internacional S.A.B. de C.V? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Genomma Lab Internacional S.A.B. de C.V

I send you an email if I find something interesting about Genomma Lab Internacional S.A.B. de C.V.


Comments

How you think about this?

Leave a comment

Stay informed about Genomma Lab Internacional S.A.B. de C.V.

Receive notifications about Genomma Lab Internacional S.A.B. de C.V in your mailbox!